Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants

Wan et al., Emerging Microbes & Infections, doi:10.1080/22221751.2026.2713323, Aug 2026
In vitro study evaluating the neutralization of pemivibart and SA55 monoclonal antibodies against SARS-CoV-2 variants using human nasal organoids and conventional cell lines. Pemivibart lost ~60–80-fold potency against the current XFG and KP.3.1.1 subvariants, while SA55 neutralized all variants tested with IC50 ≤ 40 ng/mL and cut BA.5.2 and XFG replication by over 3 log units.
Efficacy is variant dependent. In Vitro research shows reduced efficacy against KP.3.1.1, KP.1.1, LB.1, KP.3.3, and XEC variants1-4.
2 preclinical studies support the efficacy of pemivibart for COVID-19:
2 in vitro studies5,6
Wan et al., 12 Aug 2026, China, peer-reviewed, 21 authors. Contact: jiezhou@hku.hk.
In vitro studies are an important part of preclinical research, however results may be very different in vivo.
Abstract: ta C Taylor & Francis + al C al C Latil A es C CrossMark Emerging Microbes & Infections ISSN: 2222-1751 (Online) Journal homepage: www.tandfonline.com/journals/temi20 Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants Zhixin Wan, Ying Zhou, Fanchong Jian, Jiali Wu, Wei Xue , Man Chun Chiu, Yifei Yu, Qiaoshuai Lan, Shuxin Zhang , Zijun Zhao, Xiaoxin Zhu , Jingjing Huang , Yidong Yang, Yuhong Liu, Xinjie Meng, Lin Huang , Xiang Gao, Hin Chu, Cun Li, Yunlong Cao & Jie Zhou To cite this article: Zhixin Wan, Ying Zhou, Fanchong Jian, Jiali Wu, Wei Xue , Man Chun Chiu, Yifei Yu, Qiaoshuai Lan, Shuxin Zhang , Zijun Zhao, Xiaoxin Zhu , Jingjing Huang , Yidong Yang, Yuhong Liu, Xinjie Meng, Lin Huang , Xiang Gao, Hin Chu, Cun Li, Yunlong Cao & Jie Zhou (2026) Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants, Emerging Microbes & Infections, 15:1, 2713323, DOI: 10.1080/22221751.2026.2713323 To link to this article: https://doi.org/10.1080/22221751.2026.2713323 © 2026 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd View supplementary material Published online: 12 Aug 2026. Submit your article to this journal Article views: 874 View related articles View Crossmark data EMERGING AND RE-EMERGING CORONAVIRUSES Organoid-based evaluation of SA55 and Pemivibart against evolving SARSCoV-2 variants ``` Zhixin Wan a # , Ying Zhou a,b # , Fanchong Jian c , Jiali Wu a , Wei Xue a , Man Chun Chiu a,b , Yifei Yu a,b , Qiaoshuai Lan a,b , Shuxin Zhang a , Zijun Zhao a , Xiaoxin Zhu a,b , Jingjing Huang a,b , Yidong Yang a , Yuhong Liu a,b , Xinjie Meng a , Lin Huang d , Xiang Gao e , Hin Chu a,b,f,g , Cun Li a , Yunlong Cao c and Jie Zhou a,b,d,f,g ``` a Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; b Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People's Republic of China; c Biomedical Pioneering Innovation Center, School of Life Sciences, Peking University, Beijing, People's Republic of China; d BiomOrgan Ltd, Hong Kong, People's Republic of China; e Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, People's Republic of China; f State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; g Pandemic Research Alliance Unit at The University of Hong Kong, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China ABSTRACT Pemivibart, a class 1/4 monoclonal antibody (mAb), is currently the only FDA-authorized SARS-CoV-2 mAb under an Emergency Use Authorization (EUA) in clinical use. The emergence of subvariants, including KP.3.1.1 and XFG, raises concerns about antibody efficacy. SA55, a fully human class 1/4 mAb, is currently under clinical trial, including a nasal spray formulation. Using the well-validated organoid-based neutralization assays, we compared the potency and breadth of Pemivibart and SA55. Our results demonstrated a significant ..
DOI record: { "DOI": "10.1080/22221751.2026.2713323", "ISSN": [ "2222-1751" ], "URL": "http://dx.doi.org/10.1080/22221751.2026.2713323", "alternative-id": [ "10.1080/22221751.2026.2713323" ], "article-number": "2713323", "assertion": [ { "label": "Peer Review Statement", "name": "peerreview_statement", "order": 1, "value": "The publishing and review policy for this title is described in its Aims & Scope." }, { "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=temi20", "label": "Aim & Scope", "name": "aims_and_scope_url", "order": 2, "value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=temi20" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Received", "name": "received", "order": 0, "value": "2026-04-21" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Revised", "name": "revised", "order": 1, "value": "2026-06-28" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "2026-07-29" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Published", "name": "published", "order": 3, "value": "2026-08-12" } ], "author": [ { "ORCID": "https://orcid.org/0009-0005-4411-6659", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Wan", "given": "Zhixin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0003-1443-8874", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Zhou", "given": "Ying", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-8703-3507", "affiliation": [ { "name": "Peking University", "place": [ "Beijing, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Jian", "given": "Fanchong", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-7935-3946", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Wu", "given": "Jiali", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Xue", "given": "Wei", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-9503-6396", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Chiu", "given": "Man Chun", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0005-0236-3213", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Yu", "given": "Yifei", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-5524-3542", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Lan", "given": "Qiaoshuai", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Zhang", "given": "Shuxin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0008-6283-2343", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Zhao", "given": "Zijun", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Zhu", "given": "Xiaoxin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Huang", "given": "Jingjing", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0004-7696-3943", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Yang", "given": "Yidong", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-1469-271X", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Liu", "given": "Yuhong", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-6169-5729", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Meng", "given": "Xinjie", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "BiomOrgan Ltd", "place": [ "Hong Kong, People’s Republic of China" ] } ], "family": "Huang", "given": "Lin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-1710-4204", "affiliation": [ { "name": "Beijing Institute of Biotechnology", "place": [ "Beijing, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Gao", "given": "Xiang", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-2855-9837", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Chu", "given": "Hin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-3003-0000", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Li", "given": "Cun", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-5918-1078", "affiliation": [ { "name": "Peking University", "place": [ "Beijing, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Cao", "given": "Yunlong", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "BiomOrgan Ltd", "place": [ "Hong Kong, People’s Republic of China" ] }, { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Zhou", "given": "Jie", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" } ], "container-title": "Emerging Microbes & Infections", "container-title-short": "Emerging Microbes & Infections", "content-domain": { "crossmark-restriction": true, "domain": [ "www.tandfonline.com" ] }, "created": { "date-parts": [ [ 2026, 8, 3 ] ], "date-time": "2026-08-03T14:18:49Z", "timestamp": 1785766729000 }, "deposited": { "date-parts": [ [ 2026, 8, 12 ] ], "date-time": "2026-08-12T18:35:35Z", "timestamp": 1786559735000 }, "funder": [ { "DOI": "10.13039/501100018537", "award": [ "2025ZD01904200" ], "award-info": [ { "award-number": [ "2025ZD01904200" ] } ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100018537", "id-type": "DOI" } ], "name": "National Science and Technology Major Project" }, { "award": [ "CID-HKU1-3" ], "award-info": [ { "award-number": [ "CID-HKU1-3" ] } ], "name": "Control of Infectious Diseases" }, { "award": [ "COVID1903010-project 11" ], "award-info": [ { "award-number": [ "COVID1903010-project 11" ] } ], "name": "novel coronavirus disease" }, { "award": [ "2021YFC0866100" ], "award-info": [ { "award-number": [ "2021YFC0866100" ] } ], "name": "National Key R&D Program" }, { "DOI": "10.13039/501100008804", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100008804", "id-type": "DOI" } ], "name": "Ministry of Science and Technology" }, { "award": [ "GRF" ], "award-info": [ { "award-number": [ "GRF" ] } ], "name": "General Research Fund" }, { "award": [ "17105420" ], "award-info": [ { "award-number": [ "17105420" ] } ], "name": "General Research Fund" }, { "award": [ "17113724" ], "award-info": [ { "award-number": [ "17113724" ] } ], "name": "General Research Fund" }, { "award": [ "CRF" ], "award-info": [ { "award-number": [ "CRF" ] } ], "name": "Collaborative Research Fund" }, { "award": [ "C7042-21G" ], "award-info": [ { "award-number": [ "C7042-21G" ] } ], "name": "Collaborative Research Fund" } ], "indexed": { "date-parts": [ [ 2026, 8, 12 ] ], "date-time": "2026-08-12T19:27:52Z", "timestamp": 1786562872089, "version": "build-2736575974" }, "is-referenced-by-count": 0, "issue": "1", "issued": { "date-parts": [ [ 2026, 8, 12 ] ] }, "journal-issue": { "issue": "1", "published-print": { "date-parts": [ [ 2026, 12, 31 ] ] } }, "language": "en", "license": [ { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 8, 12 ] ], "date-time": "2026-08-12T00:00:00Z", "timestamp": 1786492800000 } }, { "URL": "https://doi.org/10.1080/policies-text-data-mining", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 8, 12 ] ], "date-time": "2026-08-12T00:00:00Z", "timestamp": 1786492800000 } } ], "link": [ { "URL": "https://www.tandfonline.com/doi/pdf/10.1080/22221751.2026.2713323", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.tandfonline.com/doi/full-xml/10.1080/22221751.2026.2713323", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.tandfonline.com/doi/pdf/10.1080/22221751.2026.2713323", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "301", "original-title": [], "prefix": "10.1080", "published": { "date-parts": [ [ 2026, 8, 12 ] ] }, "published-online": { "date-parts": [ [ 2026, 8, 12 ] ] }, "published-print": { "date-parts": [ [ 2026, 12, 31 ] ] }, "publisher": "Informa UK Limited", "reference": [ { "DOI": "10.1001/jama.2024.18589", "doi-asserted-by": "publisher", "key": "e_1_3_4_2_1" }, { "DOI": "10.1016/S1473-3099(25)00308-1", "doi-asserted-by": "publisher", "key": "e_1_3_4_3_1" }, { "DOI": "10.1056/NEJMc2410203", "doi-asserted-by": "publisher", "key": "e_1_3_4_4_1" }, { "DOI": "10.20411/pai.v10i1.752", "doi-asserted-by": "publisher", "key": "e_1_3_4_5_1" }, { "article-title": "Neutralization of recent SARS-CoV-2 variants by genetically and structurally related mAbs of the pemivibart lineage", "author": "Powers C", "first-page": "2024.11.11.6231", "journal-title": "bioRxiv", "key": "e_1_3_4_6_1", "unstructured": "Powers C, Williams B, Kreher A, et al. Neutralization of recent SARS-CoV-2 variants by genetically and structurally related mAbs of the pemivibart lineage. bioRxiv. 2024:2024.11.11.623127.", "year": "2024" }, { "DOI": "10.1016/j.celrep.2022.111845", "doi-asserted-by": "publisher", "key": "e_1_3_4_7_1" }, { "DOI": "10.1016/j.chom.2022.09.018", "doi-asserted-by": "publisher", "key": "e_1_3_4_8_1" }, { "DOI": "10.3390/pharmaceutics17010043", "doi-asserted-by": "publisher", "key": "e_1_3_4_9_1" }, { "DOI": "10.1038/s41421-022-00422-1", "doi-asserted-by": "publisher", "key": "e_1_3_4_10_1" }, { "DOI": "10.1073/pnas.2300376120", "doi-asserted-by": "publisher", "key": "e_1_3_4_11_1" }, { "DOI": "10.1073/pnas.2509616122", "doi-asserted-by": "publisher", "key": "e_1_3_4_12_1" }, { "DOI": "10.1093/cid/ciaf265", "doi-asserted-by": "publisher", "key": "e_1_3_4_13_1" }, { "DOI": "10.1111/cts.70421", "doi-asserted-by": "publisher", "key": "e_1_3_4_14_1" }, { "article-title": "Antibody transcytosis and neutralizing activity in respiratory epithelial cells", "author": "Anaya EU", "first-page": "2026.05.25.7276", "journal-title": "bioRxiv", "key": "e_1_3_4_15_1", "unstructured": "Anaya EU, Vue Y, Li M, et al. Antibody transcytosis and neutralizing activity in respiratory epithelial cells. bioRxiv. 2026:2026.05.25.727697.", "year": "2026" }, { "DOI": "10.1038/s41586-020-2575-3", "doi-asserted-by": "publisher", "key": "e_1_3_4_16_1" } ], "reference-count": 15, "references-count": 15, "relation": {}, "resource": { "primary": { "URL": "https://www.tandfonline.com/doi/full/10.1080/22221751.2026.2713323" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants", "type": "journal-article", "update-policy": "https://doi.org/10.1080/tandf_crossmark_01", "volume": "15" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit